Publications by authors named "Jort Vellinga"

Claim this Profile
B
Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine.
Marijn van der Neut Kolfschoten, Hanna Inganäs, Clara Perez-Peinado, Joao Calado da Silva Freire, Jelle M Melchers, Jort Vellinga

J Thromb Haemost· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2.
Maarten Swart, Joan van der Lubbe, Sonja Schmit-Tillemans, Ella van Huizen, Johan Verspuij, Jort Vellinga

NPJ Vaccines· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Noe B Mercado, Roland Zahn, Frank Wegmann, Carolin Loos, Abishek Chandrashekar, Jort Vellinga

Nature· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Noe B Mercado, Roland Zahn, Frank Wegmann, Carolin Loos, Abishek Chandrashekar, Jort Vellinga

Nature· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.
Rinke Bos, Lucy Rutten, Joan E M van der Lubbe, Mark J G Bakkers, Gijs Hardenberg, Jort Vellinga

NPJ Vaccines· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
αvβ3 Integrin Is Required for Efficient Infection of Epithelial Cells with Human Adenovirus Type 26.
Davor Nestić, Taco G Uil, Jiangtao Ma, Soumitra Roy, Jort Vellinga

J Virol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses.
Marija Vujadinovic, Selina Khan, Koen Oosterhuis, Taco G Uil, Kerstin Wunderlich, Jort Vellinga

Vaccine· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in Adenoviral Capsid-Display Vaccines.
Marija Vujadinovic, Jort Vellinga

Biomedicines· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus vector-based prime-boost vaccination via heterologous routes induces cervicovaginal CD8 T cell responses against HPV16 oncoproteins.
Nicolas Çuburu, Selina Khan, Cynthia D Thompson, Rina Kim, Jort Vellinga

Int J Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, Ariane Rodriguez, Robin Steigerwald

PLoS One· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, Ariane Rodriguez, Robin Steigerwald

PLoS One· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenoviral Type 35 and 26 Vectors with a Bidirectional Expression Cassette in the E1 Region Show an Improved Genetic Stability Profile and Potent Transgene-Specific Immune Response.
Marija Vujadinovic, Kerstin Wunderlich, Benoit Callendret, Marina Koning, Mark Vermeulen, Jort Vellinga

Hum Gene Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform.
Nadine C Salisch, Marija Vujadinovic, Esmeralda van der Helm, Dirk Spek, Lars Vorthoren, Jort Vellinga

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a replication-deficient adenoviral vector-based vaccine candidate for the interception of HPV16- and HPV18-induced infections and disease.
Selina Khan, Koen Oosterhuis, Kerstin Wunderlich, Evelien M Bunnik, Melissa Bhaggoe, Jort Vellinga

Int J Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
Myra N Widjojoatmodjo, Lies Bogaert, Bob Meek, Roland Zahn, Jort Vellinga

Vaccine· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An alternative to the adenovirus inverted terminal repeat sequence increases the viral genome replication rate and provides a selective advantage in vitro.
Kerstin Wunderlich, Esmeralda van der Helm, Dirk Spek, Mark Vermeulen, Adile Gecgel, Jort Vellinga

J Gen Virol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in manufacturing adenoviral vectors for global vaccine product deployment.
Jort Vellinga, J Patrick Smith, Agnieszka Lipiec, Dragomira Majhen, Angelique Lemckert

Hum Gene Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species.
Roland Zahn, Gert Gillisen, Anna Roos, Marina Koning, Esmeralda van der Helm, Jort Vellinga

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling.
Jens H W Pahl, Dirk H J Verhoeven, Kitty M C Kwappenberg, Jort Vellinga, Arjan C Lankester

Mol Immunol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge.
Thomas W Geisbert, Michael Bailey, Lisa Hensley, Clement Asiedu, Joan Geisbert, Jort Vellinga

J Virol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directed adenovirus evolution using engineered mutator viral polymerases.
Taco G Uil, Jort Vellinga, Jeroen de Vrij, Sanne K van den Hengel, Martijn J W E Rabelink

Nucleic Acids Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A lentiviral vector-based adenovirus fiber-pseudotyping approach for expedited functional assessment of candidate retargeted fibers.
Taco G Uil, Jeroen de Vrij, Jort Vellinga, Martijn J W E Rabelink, Steve J Cramer

J Gene Med· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replacement of native adenovirus receptor-binding sites with a new attachment moiety diminishes hepatic tropism and enhances bioavailability in mice.
Frederik H E Schagen, Harm C A Graat, Jan E Carette, Jort Vellinga, Michael A van Geer

Hum Gene Ther· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A system for efficient generation of adenovirus protein IX-producing helper cell lines.
Jort Vellinga, Taco G Uil, Jeroen de Vrij, Martijn J W E Rabelink, Leif Lindholm

J Gene Med· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The adenovirus capsid: major progress in minor proteins.
Jort Vellinga, Stephanie Van der Heijdt, Rob C Hoeben

J Gen Virol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis